August 17, 2024 August 17, 2024Categories News StoriesNivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)
August 1, 2024 August 1, 2024Categories News StoriesAdvocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems
July 9, 2024 July 9, 2024Categories News StoriesECOG-ACRIN research advocate and prostate cancer survivor Brian Jones is profiled in Cancer Today
July 2, 2024 July 2, 2024Categories Announcements News StoriesThe Summer 2024 advocacy blog, Considering Clinical Trials, is now available
June 18, 2024 June 18, 2024Categories News StoriesDr. Barbara Burtness and colleagues highlight progress in head and neck cancer MRD at ASCO, but caution that results remain preliminary (free registration is required to view this article)
June 14, 2024 June 14, 2024Categories News StoriesE1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)
June 13, 2024 June 13, 2024Categories News StoriesNivolumab fails to benefit esophageal cancer treatment in the EA2174 trial: Dr. Jennifer Eads
June 13, 2024 June 13, 2024Categories News StoriesDr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)
June 13, 2024 June 13, 2024Categories News StoriesPersonalizing chemotherapy for Black women in study EAZ171 (story by the Susan G. Komen organization)
